Top Menu

Acting Assistant AG Rabbitt Talks White-Collar Crime

rabbitt

Recently Acting Assistant Attorney General Brian Rabbitt delivered this virtual speech to a White Collar Crime workshop.

As excerpted below, Rabbitt touched upon a variety of white-collar crime topics including individual accountability, DOJ policy, and data analytics.

Regarding white-collar crime generally, Rabbitt stated:

Continue Reading

Pfizer In The News For Two Materially Different Reasons

pfizer

In recent days, Pfizer has been in the news cycle for two materially different reasons.

Indeed, the juxtaposition is striking.

First, Pfizer (a company that resolved an approximate $60 million Foreign Corrupt Practices Act enforcement action in 2012 concerning conduct in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia) has been under renewed FCPA scrutiny since 2019 and recently disclosed as follows:

Continue Reading

Friday Roundup

Roundup

Fear based marketing, not a victim, dismissed, and for the reading stack.

It’s all here in the Friday roundup.

Fear Based Marketing

Another example of lawyers trying to market the COVID-19 situation by asserting that “the novel and exigent circumstances brought on by the pandemic significantly increase companies’ risk exposure under the Foreign Corrupt Practices Act and global anti-bribery laws.”

The piece even uses the personal protective equipment hypothetical that not even top DOJ officials seemed to be concerned about. (See here).

Continue Reading

FCPA Enforcement Officials Address COVID-19 Related Questions

Soapbox

Earlier this week, Daniel Kahn (Sentior Deputy Chief, DOJ Criminal Division – Fraud Section) and Charles Cain (SEC FCPA Unit Chief) participated in this webinar.

During the webinar, Kahn and Cain addressed a variety questions related to their respective enforcement agencies relative to the COVID-19 crisis.

Set forth below are the issues addressed and their responses.

Continue Reading

Powered by WordPress. Designed by WooThemes